8 results
8-K
EX-99.1
EYPT
EyePoint Pharmaceuticals Inc
13 Sep 23
Other Events
7:06am
thickness measured by vertical and horizontal OCT scans <1% Overall loss of ONL vs control ONL: Outer Nuclear Layer Data presented at ARVO 2023
EYP
8-K
EX-99.2
EYPT
EyePoint Pharmaceuticals Inc
27 Jul 23
Other Events
4:06pm
scans <1% Overall loss of ONL vs control ONL: Outer Nuclear Layer Data presented at ARVO 2023
NON-PROLIFERATIVE DIABETIC RETINOPATHY - PHASE 2
6-K
EX-99.1
n0oh2mwm81e9cbxfw
21 Jun 05
BrachySilâ„¢ Cancer Therapy Achieves Primary Endpoint
12:00am
20FR12G
EX-4.3
cdfb93x21cino jg
20 Jan 05
Initial registration of securities (foreign private issuers)
12:00am
- Prev
- 1
- Next